U.S. Beverage Stock News

NYSE:HLIO
NYSE:HLIOMachinery

Helios Technologies (HLIO) Earnings Rebound Tests Bullish Margin Expansion Narrative

Helios Technologies (HLIO) closed out FY 2025 with fourth quarter revenue of US$210.7 million and basic EPS of US$0.59, alongside trailing twelve month EPS of US$1.46 and revenue of US$839 million that came with 24.5% earnings growth and higher net profit margins year on year. Over the last few quarters, the company has reported revenue between US$195.5 million and US$220.3 million per quarter, with basic EPS ranging from US$0.22 to US$0.59. This sets up a picture of earnings that are growing...
NYSE:GL
NYSE:GLInsurance

Globe Life Dividend Hike And Insider Sale Spark Valuation Questions

Globe Life (NYSE:GL) announced an increase in its quarterly dividend, approved by the Board of Directors. Executive Vice President and Chief Strategy Officer Michael Clay Majors reported a significant sale of Globe Life shares. The combination of a higher dividend and sizable insider selling is drawing attention to management signals and capital allocation. Globe Life, trading at $144.69 at the last close, has seen its share price rise 1.7% over the past week, 3.2% over the past month, and...
NYSE:CCO
NYSE:CCOMedia

Is Clear Channel Outdoor Holdings (CCO) Pricing Reflect Recent 84% One Year Share Gain?

Investors wondering if Clear Channel Outdoor Holdings at around US$2.39 is still offering value, or if the easy gains are already behind it, can use this article to unpack what the current price really implies. The stock has posted returns of 0.8% over the last 7 days, 14.4% over 30 days, 12.7% year to date, 83.8% over 1 year and 60.4% over 3 years. These figures put recent moves and risk perceptions firmly in focus. Recent headlines around Clear Channel Outdoor Holdings have been less about...
NasdaqGS:SGRY
NasdaqGS:SGRYHealthcare

Surgery Partners (SGRY) Loss Narrows To US$0.12 EPS As Profitability Narrative Gains Traction

How Surgery Partners' FY 2025 Numbers Set Up the Next Phase of Its Story Surgery Partners (SGRY) has closed out FY 2025 with fourth quarter revenue of US$885 million and a basic EPS loss of US$0.12, alongside a full year trailing revenue base of about US$3.3 billion and a trailing EPS loss of US$0.61. The company has seen quarterly revenue move from US$770.4 million in Q3 2024 to US$821.5 million in Q3 2025 and US$885 million in Q4 2025. Over the same period, quarterly EPS moved from a loss...
NYSE:MFA
NYSE:MFAMortgage REITs

Stronger Earnings and New US$200 Million Buyback Might Change The Case For Investing In MFA (MFA)

MFA Financial, Inc. recently reported that fourth-quarter 2025 net income rose to US$54.32 million, with basic earnings per share from continuing operations of US$0.42, and also authorized a new share repurchase program of up to US$200 million through the end of 2028. Alongside this earnings improvement, the board declared quarterly dividends on its Series B and Series C preferred shares, including a higher floating-rate payout on Series C that highlights the impact of current short-term...
NasdaqGM:EXPI
NasdaqGM:EXPIReal Estate

eXp World Expands Data Tools And European Reach While Managing Losses

eXp World Holdings (NasdaqGM:EXPI) agreed a partnership with Land id to expand its property data capabilities. The company is extending its international footprint into Romania and the Netherlands, with Luxembourg expected to follow. These updates relate to eXp’s digital real estate platform and global brokerage operations. eXp World Holdings runs a cloud based real estate brokerage and related digital services, so data quality and geographic reach are central to its business model. The...
NYSE:CW
NYSE:CWAerospace & Defense

Curtiss-Wright Wins New Defense Work As Valuation Stays Elevated

Curtiss-Wright (NYSE:CW) entered a partnership with Averna to develop custom aerospace test systems, integrating advanced testing technology into its production process. The company secured a multi-year U.S. Department of Defense contract to supply shipboard helicopter handling systems, including RAST technology, to the U.S. Naval Air Warfare Center. Curtiss-Wright operates at the intersection of aerospace and defense hardware, supplying mission-critical systems to original equipment...
NasdaqGS:CRDO
NasdaqGS:CRDOSemiconductor

Credo Technology (CRDO) Net Margin Breakout Tests Bearish Narratives In Q3 2026

Credo Technology Group Holding (CRDO) has just posted Q3 2026 results with revenue of US$407.0 million and basic EPS of US$0.86, set against a trailing twelve month net income of US$339.8 million that reflects very large year over year earnings growth and a move into profitability over the last five years. The company has seen revenue move from US$135.0 million and basic EPS of US$0.17 in Q3 2025 to US$407.0 million and US$0.86 in Q3 2026, alongside trailing twelve month EPS stepping up from...
NYSE:SLG
NYSE:SLGOffice REITs

Is SL Green Realty (SLG) Fairly Priced After Recent Share Price Volatility?

If you are wondering whether SL Green Realty's current share price really reflects what the business is worth, looking closely at how it is valued can help you frame that question more clearly. The stock last closed at US$39.05, with a 6.5% gain over the past week, a 12.8% decline over the last 30 days, a 16.8% decline year to date, a 33.8% decline over 1 year, a 43.6% return over 3 years, and a 28.0% decline over 5 years, which gives you a mixed picture of recent and longer term...
NYSE:BOBS
NYSE:BOBSSpecialty Retail

Director’s Post IPO Sale Puts Bob’s Discount Furniture Alignment In Focus

Director Jennifer Lynn Davis has sold a substantial stake in Bob's Discount Furniture around the time of the company's IPO. The transaction involves insider shares in NYSE:BOBS, drawing attention to governance and ownership changes as the company enters public markets. Investors are watching how this sale fits into Bob's Discount Furniture's broader post-IPO plans and capital structure. Bob's Discount Furniture, now trading as NYSE:BOBS, operates in the value focused home furnishings...
NYSE:LTH
NYSE:LTHHospitality

Is It Time To Reassess Life Time Group Holdings (LTH) After Recent Share Price Declines?

Wondering if Life Time Group Holdings is priced attractively at its recent US$26.16 close, or if the market is asking too much for the stock? This article walks through the numbers to help you frame that question. The share price has seen mixed performance, with a 6.1% decline over the last 7 days and a 10.3% decline over 30 days, while the 3 year return sits at 40.0% and the 1 year return at a 17.2% decline. Recent coverage has focused on Life Time Group Holdings as a fitness and lifestyle...
NYSE:PEN
NYSE:PENMedical Equipment

Penumbra Sale To Boston Scientific Puts Focus On Deal Terms And Future

Penumbra (NYSE:PEN) has entered into a definitive agreement to be acquired by Boston Scientific. The all cash transaction values Penumbra at approximately US$14.5b. The deal is subject to approval by Penumbra shareholders and other customary closing conditions. Penumbra focuses on medical devices for neurovascular and peripheral vascular conditions, areas that continue to attract attention as populations age and care standards evolve. Boston Scientific’s agreement to acquire NYSE:PEN adds...
NasdaqGS:ROOT
NasdaqGS:ROOTInsurance

A Look At Root (ROOT) Valuation After Earnings Show Higher Revenue And Improved Full Year Profitability

Root (ROOT) is back in focus after reporting fourth quarter and full year 2025 results, with revenue and earnings per share figures giving investors fresh detail on the insurer’s recent operating performance. See our latest analysis for Root. Root’s recent earnings have arrived following a sharp pullback in its share price, with a 30 day share price return of 23.06% and a year to date share price return showing a 32.58% decline. The 1 year total shareholder return of a 63.88% decline...
NasdaqGS:DXPE
NasdaqGS:DXPETrade Distributors

DXP Enterprises Repositions For Infrastructure Growth With Acquisition Led Expansion

DXP Enterprises is shifting its core focus from oil and gas distribution to a broader industrial platform. The company is targeting sectors such as Water, Wastewater, Fire, and Data Centers, supported by fresh liquidity. An acquisition driven expansion plan is central to this repositioning of NasdaqGS:DXPE. DXP Enterprises, trading on NasdaqGS:DXPE, is drawing attention as it reshapes its business around essential infrastructure and industrial markets. The stock closed at $140.47, with a...
NasdaqGS:CLMT
NasdaqGS:CLMTOil and Gas

Calumet Debt Reset And DOE Loan Reframe Montana Renewables Story

Calumet (NasdaqGS:CLMT) reports significant debt reduction and major cost cuts as part of a wider operational reset. The company secures a large loan from the U.S. Department of Energy to support its Montana Renewables MaxSAF 150 expansion. Management highlights record Specialty Products production and ongoing portfolio changes as it advances its renewable fuels strategy. Calumet comes into this news cycle with its shares at $27.89 and a very large 5 year return, indicating the stock has...
NasdaqCM:SPT
NasdaqCM:SPTSoftware

Sprout Social (SPT) Valuation Check After New AI Features And Expanded Reddit Partnership

Sprout Social (SPT) is drawing fresh attention after announcing AI-focused product updates and a deeper Reddit partnership, moves that could influence how marketing teams assess the company’s role in high trust online communities. See our latest analysis for Sprout Social. The recent AI product launch and Reddit partnership come after a sharp reset in Sprout Social’s share price, with a 30 day share price return of a 24.31% decline and a 1 year total shareholder return of a 74.31% decline...
NasdaqGS:OUST
NasdaqGS:OUSTElectronic

Ouster (OUST) Q4 Profit Of US$4 Million Tests Bearish Narratives On Path To Profitability

Ouster (OUST) closed out FY 2025 with Q4 revenue of US$62.2 million and basic EPS of US$0.07, a sharp contrast to the loss of US$0.48 per share on US$30.1 million of revenue in Q4 2024. Over the past four reported quarters, revenue has moved from US$30.1 million in Q4 2024 to US$32.6 million, US$35.0 million and US$39.5 million through 2025. Over the same period, basic EPS shifted from a loss of US$0.48 to losses of US$0.42, US$0.38 and US$0.37 before turning slightly positive in Q4 2025...
NYSE:KEYS
NYSE:KEYSElectronic

Is It Too Late To Consider Keysight Technologies (KEYS) After A 97.6% One-Year Rally?

If you are wondering whether Keysight Technologies is still good value after its recent run, you are not alone. This article will walk through what the current price might imply. Keysight’s share price closed at US$302.54, with returns of 0.4% over 7 days, 39.9% over 30 days, 46.4% year to date and 97.6% over the past year. This naturally raises questions about how much of the story is already in the price. Recent coverage has focused on Keysight’s role in test and measurement solutions for...
NYSE:BBAI
NYSE:BBAIIT

BigBear.ai Holdings BBAI Q4 Loss Revives Bearish Narratives On Persistent Unprofitability

BigBear.ai Holdings (BBAI) just posted its FY 2025 numbers, closing out the year with Q4 revenue of US$27.3 million and a basic EPS loss of US$0.01, alongside a trailing twelve month basic EPS loss of US$0.82 on revenue of US$127.7 million. Over recent quarters the company has seen quarterly revenue move from US$43.8 million in Q4 2024 to US$27.3 million in Q4 2025. Basic EPS has ranged from a loss of US$0.58 in Q4 2024 to a small profit of US$0.01 in Q3 2025, before slipping back into a...
NYSE:NUVB
NYSE:NUVBPharmaceuticals

Nuvation Bio (NUVB) Q4 Revenue Surge Tests Bullish Growth Narrative Against Ongoing Losses

Nuvation Bio FY 2025 Earnings Snapshot Nuvation Bio (NUVB) has wrapped up FY 2025 with fourth quarter revenue of about US$41.9 million and a basic EPS loss of US$0.11, as the market weighs solid top line figures against continued bottom line pressure. The company has seen revenue move from US$5.7 million in Q4 2024 to US$41.9 million in Q4 2025, while quarterly basic EPS has ranged from a loss of US$0.15 in Q4 2024 to a loss of US$0.11 in Q4 2025 and a trailing twelve month basic EPS loss of...
NYSE:BHC
NYSE:BHCPharmaceuticals

Potential Bausch + Lomb Separation Reframes Bausch Health

Bausch Health Companies, trading at $5.73, has seen pressure on its share price over multiple time frames, with a 20.5% decline year to date and an 83.1% decline over five years. In that context, the continued work on a full split from Bausch + Lomb are central to how investors may reassess the company’s revenue mix and overall structure.
NYSE:BBY
NYSE:BBYSpecialty Retail

Best Buy (BBY) Margin Compression And One Off Loss Reinforce Bearish Earnings Narratives

Best Buy FY 2026 results: revenue steady, EPS under pressure as margins stay thin Best Buy (BBY) has reported third quarter FY 2026 results with revenue of US$9.7b and basic EPS of US$0.66, setting the tone for a year where earnings quality is very much in focus. Over the past three quarters of FY 2026, revenue has ranged from US$8.8b to US$9.7b while basic EPS moved from US$0.95 in Q1 to US$0.88 in Q2 and US$0.66 in Q3, alongside same store sales trends that went from a 0.7% decline in Q1 to...
NYSE:JOE
NYSE:JOEReal Estate

Is It Too Late To Consider St. Joe (JOE) After A Strong Share Price Run?

If you are wondering whether St. Joe's current share price still offers value, it helps to step back and look at what the numbers are really saying about the business. The stock last closed at US$72.79, with returns of 4.0% over 7 days, 10.0% over 30 days, 21.7% year to date, 56.8% over 1 year, 82.4% over 3 years and 56.4% over 5 years, which will naturally raise questions about how the current price lines up with underlying value. Investors have been watching St. Joe as it continues to...
NYSE:ADT
NYSE:ADTConsumer Services

Is ADT (ADT) Offering A Fresh Opportunity After Recent Share Price Weakness

If you are wondering whether ADT is attractively priced today or if the security specialist is a potential value trap in your portfolio, this article is for you. ADT shares last closed at US$6.85, with returns of a 13.1% decline over 7 days, a 14.4% decline over 30 days, a 14.5% decline year to date and a 7.3% decline over 1 year, while the 5 year return sits at 0.9%. These moves have kept ADT on many investors' watchlists, especially among those focused on how sentiment about home and...